At Bionano Genomics®, we are committed to unlocking understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. Our team is not afraid to venture into uncharted territory to look for answers. We welcome the curious and provide a place where those who are not satisfied with the status quo can feel at home.
Our next-generation genome mapping and analysis tools help researchers see true genome structure to fill in what’s missing from sequencing-based data. Saphyr™, our high-speed, high-throughput whole genome mapping solution, offers unmatched structural variation discovery capabilities and the ability to construct the most complete genome assemblies.
At Bionano, we are invested in the success of our customers and users around the world, and are dedicated to supporting them with the tools, resources and support they need to achieve their goals and make a real impact on improving quality of life for all.
Our next-generation genome mapping and analysis tools help researchers see true genome structure to fill in what’s missing from sequencing-based data. Saphyr™, our high-speed, high-throughput whole genome mapping solution, offers unmatched structural variation discovery capabilities and the ability to construct the most complete genome assemblies.
At Bionano, we are invested in the success of our customers and users around the world, and are dedicated to supporting them with the tools, resources and support they need to achieve their goals and make a real impact on improving quality of life for all.
Location: United States, California, San Diego
Employees: 201-500
Total raised: $104.5M
Founded date: 2003
Investors 3
| Date | Name | Website |
| - | Domain Ass... | domainvc.c... |
| - | Emerging T... | etpvc.com |
| 18.07.2021 | Ben Frankl... | sep.benfra... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 15.03.2019 | - | $41.5M | - |
| 20.11.2014 | Series C | $53M | - |
| 02.10.2013 | - | $10M | - |
Mentions in press and media 28
| Date | Title | Description |
| 07.03.2024 | Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ System | - |
| 05.03.2024 | Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024 | - |
| 20.01.2023 | Bionano to Host their Virtual Symposium, January 23-26, 2023 | Bionano to Host their Virtual Symposium, January 23-26, 2023 SAN DIEGO (PRWEB) January 20, 2023 Bionano to host their virtual Symposium, from January 23rd to 26th on the Labroots platform. At Bionano’s virtual Symposium, expect to hear from... |
| 15.01.2023 | Bionano to Accelerate Data Processing Solution for Optical Genome Mapping Workflow with NVIDIA | Bionano Genomics, announced a collaboration with NVIDIA to develop an acceleration platform for use in Bionano’s optical genome mapping (OGM) workflow. This collaboration is expected to significantly improve data processing speed while redu... |
| 05.12.2022 | Bionano Genomics to Buy Purigen Biosystems, For Up To $64M | Bionano Genomics (NASDAQ: BNGO), a San Diego, CA-based provider of genome analysis solutions, acquired Purigen Biosystems, a Pleasanton, CA-based company that develops and commercializes automated nucleic acid extraction and purification so... |
| 14.01.2022 | January 13, 2022 – Better Together: OGM + NGS Reveals More Answers to Challenging Genomic Questions in Genetic Diseases and Cancer Research | January 13, 2022 - Better Together: OGM + NGS Reveals More Answers to Challenging Genomic Questions in Genetic Diseases and Cancer Research January 13, 2022 Share Bionano Genomics capped off its 2022 Symposium with presentations demonstrati... |
| 12.01.2022 | Bionano Genomics : January 11, 2022 – Evaluation of OGM in a variety of hematological malignancies demonstrates high concordance with traditional methods, time and cost advantages, and potential for d... | January 11, 2022 - Evaluation of OGM in a variety of hematological malignancies demonstrates high concordance with traditional methods, time and cost advantages, and potential for discovery of novel therapeutic targets January 11, 2022 Shar... |
| 10.01.2022 | Bionano Genomics : January 10, 2022 – OGM in Constitutional Cytogenetics Applications Reveals More Genome Variants that Matter with Greater Sensitivity and Better Resolution than Traditional Workflows... | January 10, 2022 - OGM in Constitutional Cytogenetics Applications Reveals More Genome Variants that Matter with Greater Sensitivity and Better Resolution than Traditional Workflows Which Increases Success Rates and Improves Stratification ... |
| 22.12.2021 | Bionano Genomics : 2022 Virtual Symposium | Bionano Genomics 2022 Virtual Symposium December 22, 2021 Share On January 10, Bionano Genomics kicks off its flagship event - the 2022 Symposium - to showcase the Company's work to transform how the world sees the genome. More than 25 este... |
| 15.03.2019 | Bionano Genomics Finds $41.5M In PIPE | San Diego-based Bionano Genomics, a developer of life sciences instrumentation for the genome analysis market, has raised $41.5M in a combination of debt and equity, the company said late Thursday. The publicly traded company, which trades ... |
Show more